Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 34,501 Maze Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 2, 2026

On Oct 1, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 34,501 Maze Therapeutics, Inc. shares at an average US$27.02 for US$932K under a trading plan, leaving 191,447 shares. Filed Oct 2, 2026 (Form 4).

Sold
34,501 shares
Price
US$27.02 average (US$27.02 to US$27.02)
Value
US$932K
Holding after
191,447 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockSale2,593US$27.0215,558Indirect
Oct 1, 2026Common StockSale31,908US$27.02191,447Indirect

Source

View original at SEC

Related